OTP Update

CAR-T: A DEMI-DECADE IN THE REAL WORLD

BlueRock Therapeutics

Satellite Biosciences

INNOVATIVE PAYMENT SOLUTIONS – RECENT LEARNINGS FROM GENE THERAPY LAUNCHES

THE EU JOINT HEALTH TECHNOLOGY ASSESSMENT: A FIT FOR PURPOSE JCA?

WELCOME REMARKS

THE FUTURE OF GENETIC MEDICINE

A FORECAST ON THE 2024 CGTX LANDSCAPE

ARM STRATEGIC INITIATIVES

REDEFINING THE GLOBAL REGULATORY LANDSCAPE FOR ATMP COMMERCIAL APPROVAL: 1 APPROVAL TO RULE THEM ALL

TISSUE REPAIR AND REGENERATION – REFLECTING ON PROGRESS FOR NOVEL TISSUE THERAPEUTICS

FIRESIDE CHAT: THE PATIENT ACCESS ENVIRONMENT FOR ATMPS IN EUROPE – THE ROLE OF EVIDENCE GENERATION

TRANSLATING EARLY RESEARCH INTO PROMISING NEW ATMPS FOR PATIENTS THROUGH PUBLIC-PRIVATE PARTNERSHIPS

DEVELOPING THE ATMP ECOSYSTEM OF THE FUTURE

ETHICS IN GENE AND CELL THERAPY

FEATURED KEYNOTE SPEAKER: DR. MASSIMO DOMINICI

STRATEGIC INVESTMENT PERSPECTIVES IN THE EVOLVING EUROPEAN AND GLOBAL ATMP LANDSCAPE

INNOVATIVE APPROACHES: DECENTRALIZED MANUFACTURING OF ATMPS

PolTREG

MaxCyte

Cellistic

GeneFab

Forge Biologics

Immpact Bio

L7 Informatics

SmartCella

Wacker Biotech

Splice Bio

CTI Clinical Trial & Consulting Services